<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.carenet.com/news/journal/carenet/63726</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-10-02</news:publication_date>
      <news:title>世界初、遺伝子編集ブタ腎臓異種移植後の同種移植／Lancet</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/journal/carenet/63725</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-10-02</news:publication_date>
      <news:title>GLP-1受容体作動薬/SGLT-2阻害薬の腎保護作用、アルブミン尿の有無で異なる？／BMJ</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63698</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-10-02</news:publication_date>
      <news:title>「定員調整」しても研修医の地域偏在解消は困難</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63686</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-10-02</news:publication_date>
      <news:title>パーソナリティ障害はストーカー行為のリスク因子なのか</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63680</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-10-02</news:publication_date>
      <news:title>小細胞肺がん、タルラタマブ3週・4週ごと投与の可能性（DeLLphi-309）／WCLC2026</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63649</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-10-02</news:publication_date>
      <news:title>肝硬変リスク、飲酒の影響が肥満や糖尿病を上回る／J Hepatol</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/clear/journal/63710</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>GLP-1/グルカゴン受容体dual agonistであるsurvodutideは肥満症治療薬として有効である（解説：住谷哲氏）</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63724</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>アザチオプリンや免疫チェックポイント阻害薬などに重大な副作用追加／厚労省</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/journal/carenet/63721</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>発症後48時間以内の脳梗塞、loberamisal追加vs.標準治療のみ／JAMA</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/journal/carenet/63720</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>小細胞肺がんの2次治療、tambotatug pelitecanでOSが有意に延長／NEJM</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63687</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>生殖細胞系列病的バリアントを有する乳がん、出産10年以降の診断と授乳歴でOS良好／ESMO Open</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63685</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>早期および晩期発症のアルツハイマー病における抗Aβ免疫療法後の脳容積推移</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63677</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>EGFR exon20挿入変異陽性NSCLCに対するアミバンタマブ＋化学療法のOS最終結果（PAPILLON）／WCLC2026</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://www.carenet.com/news/general/carenet/63650</loc>
    <news:news>
      <news:publication>
        <news:name>CareNet.com</news:name>
        <news:language>ja</news:language>
      </news:publication>
      <news:access>Registration</news:access>
      <news:genres>OpEd</news:genres>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>高齢者の骨折予防にビタミンD補充は有効か</news:title>
      <news:keywords>medicalnews</news:keywords>
    </news:news>
  </url>
</urlset>
